Niederer Kraft Frey (“NKF”) advised GreenState, a swiss vertical farming company, on its acquisition of Yasai, advised by Walder Wyss. The combination of GreenState and Yasai’s technologies will result in the creation of a
Tags :cn2
Bär & Karrer advised Banque Cantonale de Genève, e in the recent capital increase of La Foncière, a listed real estate fund. From June 3 to June 12, 2024, La Foncière successfully completed a
Scope Law advises Yunex Traffic on the acquisition Traffic Regulation Systems (TRR) division of cablex, Bern, Switzerland, a Swisscom subsidiary specializing in the construction, maintenance and operation of high-performance ICT and network infrastructure solutions. By
Niederer Kraft Frey (NKF) advised EDF on the acquisition of GE Vernova’s steam nuclear activities, covering conventional island equipment for nuclear power plants excluding servicing activities in the Americas. As part of the EDF,
Kontivia Beteiligungen, a Zurich based long term oriented investment firm advised by Kellerhals Carrard, led a group of swiss entrepreneurial families, advised by Baker McKenzie, in the acquisition of a majority stake in Walter Meier (
Schellenberg Wittmer advised Emerald Technology Ventures, a venture capital firm focusing on sustainable industrial innovation, in obtaining its FINMA license as asset manager of collective assets with the Swiss Financial Supervisory Authority (FINMA). Emerald Technology
Wenger Vieli advised Progile, an AI company based in Zurich, on all Swiss legal matters concerning their recent funding round. This secured funding of CHF 1.3 million, which will serve to increase the development and distribution
DocMorris (former Zur Rose Group) successfully placed CHF 200 million senior unsecured guaranteed convertible bonds due 2029. The bonds were issued by a Dutch subsi
Meyer Burger Technology has successfully completed a capital increase raising gross proceeds of approximately CHF 207 million. The transaction con
Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company pioneering allosteric modulation-based drug development,
